Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > New Press Release - Sernova Corp. Announces Change of Auditor

<< Previous

Bullboard Posts

Next >>

Comment by MustangSalleyon Oct 24, 2022 11:51am

169 Views

Post# 35043843

RE:RE:New Press Release - Sernova Corp. Announces Change of Auditor

Are you serious? Anybody can hire PWC . The fact they could of released this on Friday or in conjunction as a footnote to other significant news is head scratching. This has to be worst fluff news ever from Sva . Btw the books are so good that paid Swetlow 5 million in options? Getting good value for $1 million in IR PR . MS

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec